A	B	C	D	E	F	G	H	I	J	K	L
1	Main
2		Brand Name	Generic Name	Status	Indication	Mechanism	Approval	Results	Protocol	Dates	Economics	Competition
3		Avapro (irbesartan)			Hypertension	ARB	9/30/1997				SNY
4		Sustiva (efavirenz)			HIV	NNRTI	2/1/2002				1
5		Reyataz (atazanavir)			HIV	Protease Inhibitor	6/20/2003				1
6		Ixempra (ixabepilone)			mBC	Epothilone	10/16/2007				1
7		Plavix (clopidogrel)	Thrombosis	SNY	Oral	11/17/1997	Anticoagulant	Prasugrel, AZD6140, SCH530348	2011-2012
8		Abilify (aripiprazole)	Schizophrenia	65%/Otsuka	Oral	11/15/2002	Atypical Antipsychotic	Zyprexa, Seroquel, Risperdal	2014-2015
9		Nulojix (belatacept)	Organ transplant rejection	1	IV	6/15/2011			Protein
10		Onglyza (saxaglipitin)	Type 2 Diabetes	AZN	Oral	7/31/2009	DPPIV inhibitor
11
12							Phase
13		BMS-562086	pexacerfont	Discontinued - No Longer in Pipeline as of 7/19/12	Generalized Anxiety Disorder	CRF-1 antagonist	II/III	Failed
14		BMS-562086	pexacerfont	Discontinued - No Longer in Pipeline as of 7/19/12	Irritable Bowel Syndrome	CRF-1 antagonist	II
15		BMS-562086	pexacerfont	Discontinued - No Longer in Pipeline as of 7/19/12	Major Depressive Disorder	CRF-1 antagonist	I/II
16		KOS-1022	alvespimycin	Discontinued????	Breast Cancer		II	Study Terminated	n=4	2008
17		Eliquis	apixiban	Filed at FDA, CRL	DVT/PE	Factor Xa inhibitor	III	Ongoing	n=4816 placebo-controlled	2008-2013
18		Eliquis	apixiban	Filed at FDA, CRL	Acute Coronary Syndrome	Factor Xa inhibitor	II	Unclear	n=1715 placebo-controlled	2006-2008
19		Eliquis	apixiban	Filed at FDA, CRL	Acute Medical Illness "ADOPT"	Factor Xa inhibitor	III	Unclear	n=6524 vs. enox	2007-2011
20		BMS-824393		Study Withdrawn	Hepatitis C		II	Terminated?	n=0 versus peg/ribavirin	2010
21		BMS-779788		Completed	Unknown/Atherosclerosis	Unknown	I	Unknown	MAD	2009
22		BMS-833923/XL139		Ongoing	Gastric Cancers	Smoothened/Hedgehog	I	Forthcoming	n=36 combo chemo	2009-2012	Exelixis
23		BMS-936558		Ongoing	NSCLC	PD1	I	Forthcoming	n=108 Gem+Cis	2011-2013	Ono
24		BMS-936558		Ongoing	Melanoma	PD1	I	Forthcoming	n=0	2011-2013	Ono
25		BMS-823778		Ongoing	Hypertension, Obesity, Dyslipidemia	Unknown	II	Forthcoming	n=271 vs placebo	2012-2013
26		BMS-582664	brivanib	Terminated	Cancers	VEGFR2	III	Failed
27		BMS-790052	daclatasvir	Ongoing	Hepatitis C		III	Forthcoming	n=725	2012-2014
28		BMS-650032	asunaprevir	Ongoing	Hepatitis C		III	Forthcoming	n=725	2012-2014
29		MDX-060		Completed	Hodgkin's Disease	Anti-CD30 Antibody	II	Unclear	n=74	2005-2009		Seattle Genetics???
30		BMS-690514		Completed	Cancers	EGF/VEGF Kinase (Oral)	I	Unclear	n=89	2006-2009
31		dapagliflozin	Type 2 Diabetes	AZN	Oral	CRL, EU Positive in Q112	SGLT2 inhibitor	canagliflozin	NCE
32		asunaprevir (BMS-650032)	HCV	1	Oral	II	NS3 Protease Inhibitor
33		peg-interferon lambda 1A	HCV	1	SQ	II	Interferon
34		BMS-824393	Hepatitis C	1		I	NS5A inhibitor
35		BMS-488043	HIV	1	Oral	I	Attachment Inhibitor	bevirimat (PANC)
36		daclatasvir	HCV	1	Oral	III	NS5A inhibitor	NCE
37		tanespimycin	Cancer	1		II		Protein
38		BMS-587101					LFA-1 antagonist	NCE
39		necitumumab	Cancer	LLY	IV	II	EGFr antibody
40
41
42		n=1-40 processed
43
44		Discontinuations
45
46		1989: B-M merges with Squibb.
47		Captopril (ACE inhibitor) - Capoten, Capozide
48		pravastatin (Statin) - Pravachol
49		nalodol (beta blocker) - Corgard, Corzide
50		cholestyramine (anti-cholesterol) - Questran
51		sotalol (beta blocker) - Sotacor
52		fosinopril (ACE inhibitor) - Monopril, K-Lyte
53		cefadroxil (cephalosporin) - Duricef
54		amikacin (aminoglycoside) - Cefzil
55		didanosine (ARV) - Videx
56		penicillin - Polycillin, Polymox
57		cefatrizine (cephalosporin) - Cefaperos, Zanitrin
58		etoposide (cancer) - Vepesid
59		carboplatin (cancer) - Paraplatin
60		paclitaxel (cancer) - Taxol, Platinol
61		Buspar - anti-anixety
62		Desyrel - anti-depression
63		Stadol - pain
64		Isovue - cardiology imaging
65		Prohance - MRI imaging
66		Lac-Hydrin - dry skin
67		Dovonex - vitamin D for psoriasis
68		Ovcon - oral contraceptive
69		Estrace - estrogen
70		Orthopedics - Zimmer
71		Enfamil, Prosobee, Gerber , Nutramigen, Lactofree - Baby Formulas
72		Excedrin
73		Megace